Product Attributes CAS # : 863288-34-0 Molecular Formula : C165H269N47O46 Sequence (AA) : YADAIFTQSYRKVLAQLSARKLLQDIMSR Molecular Weight : 3647.2 g/mol PubChem CID : 91971820 Half-Life : ~6-8 days Synonyms : CJC-1295 DAC, Drug Affinity Complex CJC-1295, GRF (1-29) analog with DAC, Modified GRF 1-29 with DAC Type : Synthetic research peptide (long-acting GHRH analog with albumin-binding DAC) Research Focus : Growth Hormone & IGF-1 Axis, Recovery & Performance, Longevity & Anti-Aging Scientific References Sustained ghrelin receptor activity by CJC-1295, a long-acting GHRH analog Human RCT | Animal Long-acting GHRH analog CJC-1295 elicits sustained elevations in growth hormone and IGF-I Human RCT Effects of CJC-1295 on GH secretion in adult men Human RCT Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295 Human RCT Drug Affinity Complex (DAC) technology for sustained GHRH bioactivity In vitro | Animal Growth hormone-releasing hormone analogs and their applications in metabolic research Observational | Animal GHRH analogs: mechanism, effects, and research overview Observational | Animal | In vitro GHRH and its analogues: therapeutic potential in aging and body composition Human RCT | Animal Included In The Box Every product arrives in a premium, custom-designed PEPTIDE.Power box , engineered for convenience, hygiene, and safe storage in your refrigerator
Medical-Grade GHK-Cu Therapy Administered via targeted injection or protocol-specific delivery for optimal cellular signaling
Gene Expression: The 31% Claim in Context The headline finding from Pickart and Margolinas 2018 Connectivity Map analysis (PMID: 29986520) that GHK-Cu affects 31.2% of human genes has become the single most-cited statistic in GHK-Cu marketing
Routine lab follow-up, including hormone panels, semen analysis, and metabolic checks, should be scheduled every 4 to 12 weeks depending on the protocol
The BCS ranges from 0-21 with higher score indicating better brain care
